MDS with mutated TP53 (i.e., blasts < 10%) requires the presence of a multi-hit TP53 mutation or TP53 mutations with variant allele frequency (VAF) > 10% and a complex karyotype, often with a loss of 17p. This evidence concerns the gene TP53 and myelodysplastic syndrome.